Welcome to LookChem.com Sign In|Join Free

CAS

  • or

557-34-6

Post Buying Request

557-34-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

557-34-6 Usage

Chemical Description

Zinc acetate is used in the reaction of bis-azomethine 3 to produce a chelated zinc(II) compound.

Description

Zinc acetate (chemical formula: Zn(O2CCH3)2) is a kind of salt commonly existing in the dihydrate form. It appears as colorless solid. It is produced through the reaction between zinc oxide with acetate acid. Given that zinc is an essential element for growth and development of human body, zinc acetate can be used as a dietary supplement for the treatment of zinc deficiency. It plays an important role for the synthesis of cholesterol, protein, and fats. It can also be used as an astringent, styptic and emetic. In industry, it has various kinds of applications including wood preservation, manufacturing of other zinc salts as well as ethylene acetate, being used as a dye mordant, and analytical reagent.

Chemical Properties

Zinc acetate occurs as white crystalline, lustrous plates with a faint acetic odor and an astringent taste.

Physical properties

The acetate group is capable of binding to metal ions in a variety of ways through its two oxygen atoms and several connectivities are observed for the various hydrates of zinc acetate. Anhydrous zinc acetate adopts a polymeric structure consisting of zinc coordinated to four oxygen atoms in a tetrahedral environment, each tetrahedron being connected to neighbors by the acetate groups . The acetate ligands are not bidentate. In contrast, most metal diacetates feature metals in octahedral coordination with bidentate acetate groups. In zinc acetate dihydrate the zinc is octahedral, wherein both acetate groups are bidentate. 2 - 5 - Heating pad Heating Zn(CH3CO2)2 in a vacuum results in loss of acetic anhydride, leaving a residue of ""basic zinc acetate,"" with the formula Zn4O(CH3CO2)6. This cluster compound has the tetrahedral structure shown below. This species closely resembles the corresponding beryllium compound, although it is slightly expanded with Zn-O distances ~1.97 vs ~1.63 ? for Be4O(OAc)6.

Uses

Zinc acetate anhydrous is used in the synthesis of layered Zn-arylphosphonates with potential application in sorption, ion exchange or catalysis. It is utilized in the ultrasonic preparation of zinc sulfide nanoparticles coated on silica particles. It is administered orally or parenterally as a nutritional supplement. It finds an application in the field of industries such as wood preservation, manufacturing other zinc salts, polymers, manufacture of ethylene acetate, as a dye mordant, and analytical reagent. It also acts as a plating inhibitor on primary water piping.

Preparation

Zinc acetate is prepared by the reaction of acetic acid with zinc oxide followed by crystallization (crystals of dihydrate obtained): ZnO + 2CH3COOH → (CH3COO)2Zn + H2O.

Definition

ChEBI: Zinc acetate is an acetate salt in which the cationic component is zinc(2+). It has a role as an astringent. It is a zinc molecular entity and an acetate salt.

Application

Dietary and medicinal applicationsZinc acetate is used as a dietary supplement and in lozenges used to treat the common cold. Zinc acetate alone is thought to be a more effective treatment than zinc gluconate. Zinc acetate can also be used to treat zinc deficiencies. As an oral daily supplement it is used to inhibit the body's absorption of copper as part of the treatment for Wilson's disease. Zinc acetate is also sold as an astringent in the form of an ointment, a topical lotion; or combined with an antibiotic such as erythromycin for the topical treatment of acne. Furthermore Zinc acetate is commonly sold as a topical anti-itch ointment.Industrial applicationsIndustrial applications include wood preserving, manufacturing other zinc salts, polymers, manufacture of ethylene acetate, as a dye mordant, and analytical reagent. Zinc acetate is a precursor via a sol-gel route to the transparent semi conductor zinc oxide. Zinc acetate is also used for manufacturing glazers for painting on porcelain; as a reagent in testing for albumin, tannin, phosphate; as cross-linking agents for polymers; in tobacco smoke filters; and as a topical fungicide.

Production Methods

Zinc acetate is synthesized by reacting zinc oxide with glacial acetic acid, with subsequent crystallization, separation by centrifugation, and drying and milling of the crystals. No organic solvents are used during the synthesis.

Flammability and Explosibility

Nonflammable

Pharmaceutical Applications

Zinc acetate has been used as an excipient in a variety of pharmaceutical formulations including topical gels, lotions, and solutions, and subcutaneous injections. It has also been investigated for use in an oral controlled-release formulation for water-soluble drugs in combination with sodium alginate and xanthan gum. Therapeutically, zinc acetate has been used in oral capsules for the treatment of Wilson’s disease. Zinc acetate has also been demonstrated to be effective as a spermicide in vaginal contraceptives.

Safety

Zinc acetate is used in topical pharmaceutical formulations and subcutaneous injections, where it is generally regarded as relatively nontoxic and nonirritant when used as an excipient. However, zinc acetate is poisonous by intravenous and intraperitoneal routes; it is also moderately toxic following oral consumption. Zinc acetate: LD50 (rat, oral): 2.510 g/kg LD50 (mouse, IP): 0.057 g/kg

Veterinary Drugs and Treatments

Zinc sulfate is used systemically as a nutritional supplement in a variety of species. Oral zinc acetate has been shown to reduce copper toxicity in susceptible dog breeds (Bedlington Terriers, West Highland White Terriers) with hepatic copper toxicosis. Zinc therapy may also be of benefit in the treatment of hepatic fibrosis in the dog. Zinc sulfate is used topically as an astringent and as a weak antiseptic both for dermatologic and ophthalmic conditions.

storage

Zinc acetate loses water of hydration above 101℃. Zinc acetate should be stored in an airtight container in a cool, dry, place.

Incompatibilities

Zinc acetate is incompatible with oxidizing agents, zinc salts, alkalis and their carbonates, oxalates, phosphates, and sulfides.

Regulatory Status

Included in the FDA Inactive Ingredients Database (SC injections; topical lotions and solutions). Included in medicines licensed in the UK.

References

https://en.wikipedia.org/wiki/Zinc_acetate https://pubchem.ncbi.nlm.nih.gov/compound/Zinc_acetate_dihydrate#section=GHS-Classification

Check Digit Verification of cas no

The CAS Registry Mumber 557-34-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,5 and 7 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 557-34:
(5*5)+(4*5)+(3*7)+(2*3)+(1*4)=76
76 % 10 = 6
So 557-34-6 is a valid CAS Registry Number.
InChI:InChI=1/2C2H4O2.Zn/c2*1-2(3)4;/h2*1H3,(H,3,4);

557-34-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (35792)  Zinc acetate, anhydrous, 99.98% (metals basis)   

  • 557-34-6

  • 10g

  • 422.0CNY

  • Detail
  • Alfa Aesar

  • (35792)  Zinc acetate, anhydrous, 99.98% (metals basis)   

  • 557-34-6

  • 50g

  • 1576.0CNY

  • Detail
  • Alfa Aesar

  • (H33734)  Zinc acetate, anhydrous, 99.9+%   

  • 557-34-6

  • 10g

  • 488.0CNY

  • Detail
  • Alfa Aesar

  • (H33734)  Zinc acetate, anhydrous, 99.9+%   

  • 557-34-6

  • 50g

  • 1625.0CNY

  • Detail
  • Alfa Aesar

  • (H33734)  Zinc acetate, anhydrous, 99.9+%   

  • 557-34-6

  • 250g

  • 5420.0CNY

  • Detail
  • Aldrich

  • (383317)  Zincacetate  99.99% trace metals basis

  • 557-34-6

  • 383317-25G

  • 916.11CNY

  • Detail
  • Aldrich

  • (383317)  Zincacetate  99.99% trace metals basis

  • 557-34-6

  • 383317-100G

  • 2,552.94CNY

  • Detail
  • Aldrich

  • (383317)  Zincacetate  99.99% trace metals basis

  • 557-34-6

  • 383317-500G

  • 9,313.20CNY

  • Detail

557-34-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name zinc acetate

1.2 Other means of identification

Product number -
Other names Zinc acetate anhydrous

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:557-34-6 SDS

557-34-6Synthetic route

Allyl acetate
591-87-7

Allyl acetate

phenylzinc chloride
28557-00-8

phenylzinc chloride

A

allylbenzene
300-57-2

allylbenzene

B

biphenyl
92-52-4

biphenyl

C

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
tetrakis(triphenylphosphine) palladium(0) In tetrahydrofuran Ar atmosphere; stirring (20°C, 5 mole-% catalyst, 5 h);A 100%
B 0%
C n/a
diethylzinc
557-20-0

diethylzinc

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
With acetic acid In diethyl ether N2 atmosphere; dropwise addn. of CH3COOH in Et2O to soln. of ZnEt2 (molar ratio Zn/acid 1:2), pptn.; filtration off, washing (Et2O), drying (vac.);99%
6-bromopyridine-2-carbaldehyde oxime

6-bromopyridine-2-carbaldehyde oxime

acetic acid
64-19-7

acetic acid

A

6-(bromopyridin-2-yl)methanammonium acetate

6-(bromopyridin-2-yl)methanammonium acetate

B

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
at 20℃; for 0.166667h; Inert atmosphere;A 95%
B 82 mg
sodium acetate
127-09-3

sodium acetate

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
In acetic acid Electrolysis; on electrolysis of Na acetate in acetic acid at 280V, 7mA/cmxcm, formation of acetate at Zn anode;;85%
In acetic acid Electrolysis; on electrolysis of Na acetate in acetic acid at 280V, 7mA/cmxcm, formation of acetate at Zn anode;;85%
poly(methacrylic acid)
79-41-4

poly(methacrylic acid)

acetic acid
64-19-7

acetic acid

zinc(II) carbonate
743369-26-8

zinc(II) carbonate

A

zinc diacetate
557-34-6

zinc diacetate

B

zinc methacryliate acetate
272771-37-6

zinc methacryliate acetate

Conditions
ConditionsYield
In water at 20℃; for 2h;A n/a
B 43%
acetic anhydride
108-24-7

acetic anhydride

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
With zinc hydroxide
With zinc(II) nitrate
acetic acid
64-19-7

acetic acid

A

zinc diacetate
557-34-6

zinc diacetate

B

acetaldehyde
75-07-0

acetaldehyde

C

hydrogen

hydrogen

Conditions
ConditionsYield
at 250 - 280℃; Ueberleiten ueber Zinkstaub;
carbon disulfide
75-15-0

carbon disulfide

N-nitrosoacetanilide
938-81-8

N-nitrosoacetanilide

zinc

zinc

zinc diacetate
557-34-6

zinc diacetate

acetic acid
64-19-7

acetic acid

dehydrated Zn(C2H3O2)2

dehydrated Zn(C2H3O2)2

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
at 150℃;
acetic anhydride
108-24-7

acetic anhydride

dihydrate Zn(C2H3O2)2+2 H2O

dihydrate Zn(C2H3O2)2+2 H2O

zinc diacetate
557-34-6

zinc diacetate

Zn(C2H3O2)2+2 H2O

Zn(C2H3O2)2+2 H2O

zinc diacetate
557-34-6

zinc diacetate

methanol
67-56-1

methanol

acetic acid ; tetrazinc-hexaacetate oxide
557-34-6

acetic acid ; tetrazinc-hexaacetate oxide

A

zinc diacetate
557-34-6

zinc diacetate

B

zinc oxide

zinc oxide

ethanol
64-17-5

ethanol

acetic acid ; tetrazinc-hexaacetate oxide
557-34-6

acetic acid ; tetrazinc-hexaacetate oxide

A

zinc diacetate
557-34-6

zinc diacetate

B

zinc oxide

zinc oxide

water
7732-18-5

water

acetic acid ; tetrazinc-hexaacetate oxide
557-34-6

acetic acid ; tetrazinc-hexaacetate oxide

A

zinc diacetate
557-34-6

zinc diacetate

B

zinc oxide

zinc oxide

potassium carbonate
584-08-7

potassium carbonate

zinc(II) chloride
7646-85-7

zinc(II) chloride

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
With acetic acid In water
acetic acid
64-19-7

acetic acid

zinc(II) carbonate
743369-26-8

zinc(II) carbonate

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
In not given prepn. from ZnCO3 and carboxylic acid in molar ratio 1:2;
In not given neutralizing acetic acid with the carbonate; slow evapn.;
In water at 100℃; for 3h;
zinc(II) acetate dihydrate
5970-45-6

zinc(II) acetate dihydrate

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
With chloroform byproducts: H2O; on dehydration of dihydrate with chloroform;;
In neat (no solvent) byproducts: H2O; loss of 2 mole H2O at 100 °C;;
In neat (no solvent) byproducts: H2O; vac. dehydration at 363 K, according to: G. Maslowska, A. Baranowska, Prod. Eighth Conf. Coord. Chem., Smolenice, Bratislava, 1980, pp. 269-273;
zinc(II) acetate dihydrate
5970-45-6

zinc(II) acetate dihydrate

acetic anhydride
108-24-7

acetic anhydride

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
In neat (no solvent) on react. of acetic anhydride with Zn acetate dihydrate at 10°C for a period of 27 hours;;
In neat (no solvent) on react. of acetic anhydride with Zn acetate dihydrate at 10°C for a period of 27 hours;;
nitrosoacetanilide

nitrosoacetanilide

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
In carbon disulfide byproducts: N2; decompn. of nitrosoacetanilide with Zn dust and forming of Zn acetate and N2;;
zinc(II) oxide

zinc(II) oxide

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
With acetic acid In hydrogenchloride; water; acetic acid ZnO dissoln. in solvents mixt.; evapn. to dryness (hot plate, 90°C), further drying (vac. desiccator, 4 h); X-ray diffraction;
With acetic acid In water; acetic acid ZnO dissoln. in solvents mixt.; concn. (hot plate, 90°C), air-cooling to room temp. (28+/-2°C), crystn. for 24 h, filtn., washing (ethyl alcohol), drying (vac. desiccator, 2 h); X-ray diffraction;
copper diacetate
142-71-2

copper diacetate

zinc sulfide

zinc sulfide

A

zinc diacetate
557-34-6

zinc diacetate

B

copper(II) sulfide

copper(II) sulfide

Conditions
ConditionsYield
In water shaken for 24 h at 25.0°C; evapn. of filtrate to dryness;
acetic acid
64-19-7

acetic acid

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
In acetic acid on slow heating of Zn with glacial acetic acid;;
benzaldehyde
100-52-7

benzaldehyde

acetic acid
64-19-7

acetic acid

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
In acetic acid byproducts: C6H5CH2OCOCH3; addn. of mixt. of benzaldehyde and excess acetic acid to zinc dust, stirring ( room temp., 12 h); filtration;
basic zinc acetate

basic zinc acetate

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
With H2O In neat (no solvent, solid phase) byproducts: Zn(OH)2; decompn. in solid state (moisture); IR-spectroscopy;
zinc(II) acetate * 0.5 acetic acid

zinc(II) acetate * 0.5 acetic acid

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
With acetic acid on treating with acetic acid;;
With acetic acid
With acetic acid
With acetic acid on treating with acetic acid;;
acetic anhydride
108-24-7

acetic anhydride

zinc(II) hydroxide

zinc(II) hydroxide

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
In neat (no solvent) on react. of acetic anhydride with Zn(OH)2 at 138°C for a period of 4 hours;;
at 138°C, some acetate is formed;;
at 138°C, some acetate is formed;;
In neat (no solvent) on react. of acetic anhydride with Zn(OH)2 at 138°C for a period of 4 hours;;
lead acetate
301-04-2

lead acetate

A

lead
7439-92-1

lead

B

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
In water in 0.1n soln.;;A n/a
B >99
zinc(II) nitrate hexahydrate

zinc(II) nitrate hexahydrate

sodium acetate
127-09-3

sodium acetate

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
In water Kinetics; dissolving both components in distilled water; stoichiometric concentrations: Zn 0.1 - 0.8 M, acetate 0.1 - 0.4 M; pH of solution from 4 to 6;; ultrasonic absorptions spectra;;
carbon dioxide
124-38-9

carbon dioxide

dimethyl zinc(II)
544-97-8

dimethyl zinc(II)

zinc diacetate
557-34-6

zinc diacetate

Conditions
ConditionsYield
2,6-bis[(di-t-butylphosphino)methyl]phenyl palladium trifluoroacetate In benzene CO2 was reacted with ZnMe2 in C6H6 in presence of Pd catalyst at room temp.;
Pd(methyl)((1,3-bis[(di-tert-butylphosphino)methyl]benzene)(-1H)) In benzene CO2 was reacted with ZnMe2 in C6H6 in presence of Pd catalyst at 100°C;
Pd(acetyl)((1,3-bis[(di-tert-butylphosphino)methyl]benzene)(-1H)) In benzene CO2 was reacted with ZnMe2 in C6H6 in presence of Pd catalyst at 100°C;
zinc diacetate
557-34-6

zinc diacetate

(22S)-22-Hydroxy-6β-methoxy-3α,5α-cyclocholest-24-ene
54604-95-4, 54649-48-8

(22S)-22-Hydroxy-6β-methoxy-3α,5α-cyclocholest-24-ene

A

(22S)-3β-Acetoxy-22-hydroxycholesta-5,24-diene
54604-97-6, 64938-06-3, 114718-53-5

(22S)-3β-Acetoxy-22-hydroxycholesta-5,24-diene

B

Acetic acid (S)-1-[(S)-1-((3S,10R,13S)-3-acetoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-ethyl]-4-methyl-pent-3-enyl ester
54604-96-5, 64938-05-2

Acetic acid (S)-1-[(S)-1-((3S,10R,13S)-3-acetoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-ethyl]-4-methyl-pent-3-enyl ester

Conditions
ConditionsYield
In acetic acid for 1h; Heating;A 100%
B n/a
zinc diacetate
557-34-6

zinc diacetate

TPP-=-Ph-CHO

TPP-=-Ph-CHO

4-(trans-2'-(2''-(5'',10'',15'',20''-tetraphenylporphyrinato zinc(II)yl)ethen-1'-yl))-1-benzaldehyde

4-(trans-2'-(2''-(5'',10'',15'',20''-tetraphenylporphyrinato zinc(II)yl)ethen-1'-yl))-1-benzaldehyde

Conditions
ConditionsYield
In methanol; chloroform at 20℃; for 0.333333h;100%
zinc diacetate
557-34-6

zinc diacetate

5,12-Bis-(3,5-di-tert-butyl-phenoxy)-2-(2-ethyl-hexyl)-9-[4-((5Z,10Z,15Z,19Z)-10,15,20-tri-p-tolyl-14,21,23,24-tetrahydro-porphin-5-yl)-phenyl]-anthra[2,1,9-def;6,5,10-d'e'f']diisoquinoline-1,3,8,10-tetraone

5,12-Bis-(3,5-di-tert-butyl-phenoxy)-2-(2-ethyl-hexyl)-9-[4-((5Z,10Z,15Z,19Z)-10,15,20-tri-p-tolyl-14,21,23,24-tetrahydro-porphin-5-yl)-phenyl]-anthra[2,1,9-def;6,5,10-d'e'f']diisoquinoline-1,3,8,10-tetraone

C107H98N6O6(2-)*Zn(2+)

C107H98N6O6(2-)*Zn(2+)

Conditions
ConditionsYield
In methanol; chloroform for 0.25h; Heating;100%
zinc diacetate
557-34-6

zinc diacetate

C182H178N8O13

C182H178N8O13

C182H174N8O13(2-)*Zn(2+)

C182H174N8O13(2-)*Zn(2+)

Conditions
ConditionsYield
In methanol; chloroform for 1h; Heating;100%
5,15-bis([2',2'':5'',2'''-terthiophen]-3''-yl)-2,8,12,18-tetra-n-butyl-3,7,13,17-tetramethylporphyrin

5,15-bis([2',2'':5'',2'''-terthiophen]-3''-yl)-2,8,12,18-tetra-n-butyl-3,7,13,17-tetramethylporphyrin

zinc diacetate
557-34-6

zinc diacetate

5,15-bis([2',2'':5'',2'''-terthiophen]-3''-yl)-2,8,12,18-tetra-n-butyl-3,7,13,17-tetramethylporphyrinato zinc(II)

5,15-bis([2',2'':5'',2'''-terthiophen]-3''-yl)-2,8,12,18-tetra-n-butyl-3,7,13,17-tetramethylporphyrinato zinc(II)

Conditions
ConditionsYield
In methanol; chloroform; water at 20℃; for 0.5h;100%
TPP-=-CHO

TPP-=-CHO

zinc diacetate
557-34-6

zinc diacetate

3-[(E)-4-(3-oxoprop-1-en-1-yl)]-5,10,15,20 tetraphenylporphyrinatozinc(II)

3-[(E)-4-(3-oxoprop-1-en-1-yl)]-5,10,15,20 tetraphenylporphyrinatozinc(II)

Conditions
ConditionsYield
In methanol; chloroform at 20℃; for 0.166667h;100%
1,9-bis[(propylimino)methyl]-5-phenyldipyrromethane

1,9-bis[(propylimino)methyl]-5-phenyldipyrromethane

zinc diacetate
557-34-6

zinc diacetate

2C23H26N4(2-)*2Zn(2+)

2C23H26N4(2-)*2Zn(2+)

Conditions
ConditionsYield
In ethanol at 20℃; for 0.166667h; Product distribution / selectivity;100%
4,4'-bipyridine
553-26-4

4,4'-bipyridine

zinc diacetate
557-34-6

zinc diacetate

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

[Zn2(fumarate)2(4,4'-bipyridyl)]n

[Zn2(fumarate)2(4,4'-bipyridyl)]n

Conditions
ConditionsYield
100%
C20H6N4(CH3)4(C2H5)2(C2H4COOC3H6C6H4N(CH3)2)(C2H4COOC2H4SC10H4O2(CH3))
126956-54-5

C20H6N4(CH3)4(C2H5)2(C2H4COOC3H6C6H4N(CH3)2)(C2H4COOC2H4SC10H4O2(CH3))

zinc diacetate
557-34-6

zinc diacetate

Zn(C20H4N4(CH3)4(C2H5)2(C2H4COOC3H6C6H4N(CH3)2)(C2H4COOC2H4SC10H4O2(CH3)))
134565-04-1

Zn(C20H4N4(CH3)4(C2H5)2(C2H4COOC3H6C6H4N(CH3)2)(C2H4COOC2H4SC10H4O2(CH3)))

Conditions
ConditionsYield
In methanol treatment of the ligand with a methanol soln. of zinc acetate;100%
AuC62H71N4C24H14N4C46H57CuC34H34N4O6(2+)*2PF6(1-)={AuC62H71N4C24H14N4C46H57CuC34H34N4O6}(PF6)2

AuC62H71N4C24H14N4C46H57CuC34H34N4O6(2+)*2PF6(1-)={AuC62H71N4C24H14N4C46H57CuC34H34N4O6}(PF6)2

zinc diacetate
557-34-6

zinc diacetate

AuC62H71N4C24H14N2(ZnC46H55N4)CuC34H34N2O6(2+)*2PF6(1-)={AuC62H71N4C24H14N2(ZnC46H55N4)CuC34H34N2O6}(PF6)2

AuC62H71N4C24H14N2(ZnC46H55N4)CuC34H34N2O6(2+)*2PF6(1-)={AuC62H71N4C24H14N2(ZnC46H55N4)CuC34H34N2O6}(PF6)2

Conditions
ConditionsYield
In methanol; dichloromethane refluxing of porphyrine with Zn(OAc)2 in CH2Cl2-MeOH for 1.5 h under argon; column chromy. (alumina);100%
phosphoric acid
86119-84-8, 7664-38-2

phosphoric acid

zinc diacetate
557-34-6

zinc diacetate

water
7732-18-5

water

1,2-diaminocyclohexane
694-83-7

1,2-diaminocyclohexane

Zn3(PO4)2(PO3OH)(H2-1,2-diaminocyclohexane)*2H2O

Zn3(PO4)2(PO3OH)(H2-1,2-diaminocyclohexane)*2H2O

Conditions
ConditionsYield
In water hydrothermal conditions, 180°C;100%
boron phosphate

boron phosphate

zinc diacetate
557-34-6

zinc diacetate

water
7732-18-5

water

1,2-diaminocyclohexane
694-83-7

1,2-diaminocyclohexane

Zn3(PO4)2(PO3OH)(H2-1,2-diaminocyclohexane)*2H2O

Zn3(PO4)2(PO3OH)(H2-1,2-diaminocyclohexane)*2H2O

Conditions
ConditionsYield
In water hydrothermal conditions, molar ratio BPO4:Zn(OAc)2:diaminocyclohexane:water 2:1:2.5:117, , pH=8, 210°C; elem. anal.;100%
trans-5,15-di(4-pyridyl)-10,20-diphenylporphyrin

trans-5,15-di(4-pyridyl)-10,20-diphenylporphyrin

zinc diacetate
557-34-6

zinc diacetate

C42H26N6Zn
159726-84-8

C42H26N6Zn

Conditions
ConditionsYield
In methanol; chloroform dry N2-atmosphere; stirring, refluxing (10 h, dark); evapn. (vac.), washing (MeOH), drying;100%
C72H61N6BF2

C72H61N6BF2

zinc diacetate
557-34-6

zinc diacetate

Zn(C72H59N6BF2)
214423-05-9

Zn(C72H59N6BF2)

Conditions
ConditionsYield
In methanol100%
Conditions
ConditionsYield
In toluene C60, C20H10N4((C4H9)2C6H3)3(C6H4)2(C10H2N2O4)(CHO), N-methylglycine (toluene) heated under N2 in dark for 6 h; cooled to 25°C, evapd. to dryness (reduced pressure); chromy. sepd., dissolved (CH3Cl), added Zn(OAc)2 in CH3OH, heated for 30 min; washed twice (H2O), dried (anhydrous Na2SO4), solvent evapd., chromy., reprecipitated from benzene-methanol;100%
5-(4-aminophenyl)-10,15,20-tris(3,5-di-tert-butylphenyl) porphyrin

5-(4-aminophenyl)-10,15,20-tris(3,5-di-tert-butylphenyl) porphyrin

Pyromellitic dianhydride
89-32-7

Pyromellitic dianhydride

4-hexadecylaniline
79098-13-8

4-hexadecylaniline

zinc diacetate
557-34-6

zinc diacetate

[Zn(C20H8N4((C4H9)2C6H3)3(C6H4)(C10H2N2O4)(C6H4)(C16H33))]
303955-50-2

[Zn(C20H8N4((C4H9)2C6H3)3(C6H4)(C10H2N2O4)(C6H4)(C16H33))]

Conditions
ConditionsYield
In N,N-dimethyl-formamide (C20H10N4((C4H9)2C6H3)3(C6H4))NH2, C10H2O6, (C16H33)NH(C6H5) (dry DMF) heated under N2 in dark for 22 h, cooled to 25°C, evapd. to dryness (reduced pressure); chromy., dissolved (CHCl3), added Zn(OAc)2 in CH3OH, heated for 30 min; washed twice (H2O), dried (anhydrous Na2SO4), solvent evapd., chromy., reprecipitated from chloroform-methanol;100%
5-[1'-(hexylaminomethyl)ferrocenyl]-10,15,20-tri(p-tolyl)porphyrin

5-[1'-(hexylaminomethyl)ferrocenyl]-10,15,20-tri(p-tolyl)porphyrin

zinc diacetate
557-34-6

zinc diacetate

zinc(II) 5-[1'-(hexylaminomethyl)ferrocenyl]-10,15,20-tri(p-tolyl)porphyrin
838825-87-9

zinc(II) 5-[1'-(hexylaminomethyl)ferrocenyl]-10,15,20-tri(p-tolyl)porphyrin

Conditions
ConditionsYield
In methanol; dichloromethane; water Fe(C5H4CH2NH(CH2)5CH3)(C5H4)-substituted porphyrin reacted with ZnOAc2 in CH2Cl2/MeOH/H2O for 10 h; chromy. (SiO2, CH2Cl2/MeOH); elem. anal.;100%
5,10,15-triphenyl-20-(2,6-dimethyl-4[2-(trimethylsilyl)ethynyl]phenyl)porphyrin

5,10,15-triphenyl-20-(2,6-dimethyl-4[2-(trimethylsilyl)ethynyl]phenyl)porphyrin

zinc diacetate
557-34-6

zinc diacetate

zinc(II) 5,10,15-triphenyl-20-(2,6-dimethyl-4-[2-(trimethylsilyl)ethynyl]phenyl)porphyrin
184153-99-9

zinc(II) 5,10,15-triphenyl-20-(2,6-dimethyl-4-[2-(trimethylsilyl)ethynyl]phenyl)porphyrin

Conditions
ConditionsYield
In chloroform reaction for 2.5 h;100%
[zinc(II) 5,10,15-triphenyl-20-porphinyl]-4'-[5,10,15-triphenyl-20-porphinyl]di(2,6-dimethylphenyl)ethyne

[zinc(II) 5,10,15-triphenyl-20-porphinyl]-4'-[5,10,15-triphenyl-20-porphinyl]di(2,6-dimethylphenyl)ethyne

zinc diacetate
557-34-6

zinc diacetate

ZnC20H8N4(C6H5)3C6H2(CH3)2CCC6H2(CH3)2ZnC20H8N4(C6H5)3

ZnC20H8N4(C6H5)3C6H2(CH3)2CCC6H2(CH3)2ZnC20H8N4(C6H5)3

Conditions
ConditionsYield
In chloroform reaction for 1 h;100%
[ZnC20N4H8(C6H5)3(C6H2(CH3)2CCC6H4C20N4H8H2(C6H2(CH3)3)3)]

[ZnC20N4H8(C6H5)3(C6H2(CH3)2CCC6H4C20N4H8H2(C6H2(CH3)3)3)]

zinc diacetate
557-34-6

zinc diacetate

ZnC20H8N4(C6H5)3C6H2(CH3)2CCC6H4ZnC20H8N4(C6H2(CH3)3)3
184154-17-4

ZnC20H8N4(C6H5)3C6H2(CH3)2CCC6H4ZnC20H8N4(C6H2(CH3)3)3

Conditions
ConditionsYield
In chloroform stirring (room temp., 1 h); filtration, concn.;100%
2-hydroxy-5,10,15,20-tetrakis(3',5'-di-tert-butylphenyl)porphin

2-hydroxy-5,10,15,20-tetrakis(3',5'-di-tert-butylphenyl)porphin

zinc diacetate
557-34-6

zinc diacetate

[2-hydroxy-5,10,15,20-tetrakis(3',5'-di-tert-butylphenyl)porphinato]zinc(II)
214962-06-8

[2-hydroxy-5,10,15,20-tetrakis(3',5'-di-tert-butylphenyl)porphinato]zinc(II)

Conditions
ConditionsYield
With sodium hydride; Benzaldoxime In methanol; dichloromethane; mineral oil mixt. refluxing in dark for 45 min, solvent complete removal; residue chromy. (silica, DCM), recrystn. (DCM/MeOH);100%
[((((CH3)3C)2C6H3)3C20H10N4)C6H3(O(CH2)4CH3)CONHC6H2(OCH3)2NHCOC6H3(O(CH2)CH3)]2((((CH3)3C)2C6H3)2C20H10N4)

[((((CH3)3C)2C6H3)3C20H10N4)C6H3(O(CH2)4CH3)CONHC6H2(OCH3)2NHCOC6H3(O(CH2)CH3)]2((((CH3)3C)2C6H3)2C20H10N4)

zinc diacetate
557-34-6

zinc diacetate

[((((CH3)3C)2C6H3)3C20H8N4Zn)C6H3(O(CH2)4CH3)CONHC6H2(OCH3)2NHCOC6H3(O(CH2)CH3)]2((((CH3)3C)2C6H3)2C20H8N4Zn)

[((((CH3)3C)2C6H3)3C20H8N4Zn)C6H3(O(CH2)4CH3)CONHC6H2(OCH3)2NHCOC6H3(O(CH2)CH3)]2((((CH3)3C)2C6H3)2C20H8N4Zn)

Conditions
ConditionsYield
In methanol; dichloromethane reaction of zinc compd. with porphyrin deriv. in MeOH/CH2Cl2 at room temp. for 12 h;100%
diphenyl(10,20-diphenylporphyrin-5-yl)phosphine oxide

diphenyl(10,20-diphenylporphyrin-5-yl)phosphine oxide

zinc diacetate
557-34-6

zinc diacetate

diphenyl[10,20-diphenylporphyrinatozinc(II)-5-yl]phosphine oxide
909039-64-1

diphenyl[10,20-diphenylporphyrinatozinc(II)-5-yl]phosphine oxide

Conditions
ConditionsYield
In methanol; dichloromethane a soln. of zinc acetate in methanol was added to a soln. of porphyrin inCH2Cl2, the mixt. was refluxed for 2 h; ppt. was filtered, washed three times with methanol;100%
H2(C20H8N4(C6H4CH3)3)C6H4CH2NC6H4C(CH3)2COC6H3NO2CHCH

H2(C20H8N4(C6H4CH3)3)C6H4CH2NC6H4C(CH3)2COC6H3NO2CHCH

zinc diacetate
557-34-6

zinc diacetate

Zn(C20H8N4(C6H4CH3)3)C6H4CH2NC6H4C(CH3)2COC6H3NO2CHCH
356527-60-1

Zn(C20H8N4(C6H4CH3)3)C6H4CH2NC6H4C(CH3)2COC6H3NO2CHCH

Conditions
ConditionsYield
In chloroform (Ar); stirring a soln. of ligand with excess of zinc salt in CHCl3 overnight; column chromy (SiO2);100%
zinc diacetate
557-34-6

zinc diacetate

meso-pentyldipyrromethane
147804-54-4

meso-pentyldipyrromethane

5-formyl-1,1,3,3-tetramethylisoindolin-2-yloxyl
276885-27-9

5-formyl-1,1,3,3-tetramethylisoindolin-2-yloxyl

5,10,15-tri-n-pentyl-20-(1',1',3',3'-tetramethylisoindolin-2'-yloxyl-5'-yl)porphyrinato zinc(II)
532379-02-5

5,10,15-tri-n-pentyl-20-(1',1',3',3'-tetramethylisoindolin-2'-yloxyl-5'-yl)porphyrinato zinc(II)

Conditions
ConditionsYield
With trifluoroacetic acid; 2,3-dicyano-5,6-dichloro-p-benzoquinone In methanol; dichloromethane; chloroform to soln. of 5-formyl-1,1,3,3-tetramethylisoindolin-2-yloxyl, 5-pentyldipyrromethane in CH2Cl2 under Ar, trifluoroacetic acid added, stirred for 20 min, 2,3-dichloro-5,6-dicyano-1,4-benzoquinone added stirred, evapd. to dryness, chromy., refluxed,....; elem. anal.;100%
pyropheophorbide a

pyropheophorbide a

zinc diacetate
557-34-6

zinc diacetate

zinc 3-vinyl-8-ethyl-12-methyl-bacteriopheophorbide d

zinc 3-vinyl-8-ethyl-12-methyl-bacteriopheophorbide d

Conditions
ConditionsYield
In chloroform excess of Zn(II) acetate, reflux;100%
(CH3)5(CH2)6(CH)5(C4N)3(C2NH2)(C)(CO)COOH(O)(C12H7)(CO)2

(CH3)5(CH2)6(CH)5(C4N)3(C2NH2)(C)(CO)COOH(O)(C12H7)(CO)2

zinc diacetate
557-34-6

zinc diacetate

(CH3)5(CH2)6(CH)5(C4N)3(C2N)(C)Zn(CO)COOH(O)(C12H7)(CO)2

(CH3)5(CH2)6(CH)5(C4N)3(C2N)(C)Zn(CO)COOH(O)(C12H7)(CO)2

Conditions
ConditionsYield
In chloroform excess of Zn(II) acetate, reflux;100%
(CH3)10(CH2)14(CH)11(CO)3(2O)(C4N)3(4C)(NH2)(C12H7)(CO)2

(CH3)10(CH2)14(CH)11(CO)3(2O)(C4N)3(4C)(NH2)(C12H7)(CO)2

zinc diacetate
557-34-6

zinc diacetate

(CH3)10(CH2)14(CH)11(CO)3(2O)(C4N)3(4C)(N)(C12H7)(CO)2Zn

(CH3)10(CH2)14(CH)11(CO)3(2O)(C4N)3(4C)(N)(C12H7)(CO)2Zn

Conditions
ConditionsYield
In chloroform excess of Zn(II) acetate, reflux;100%
C12H14O3

C12H14O3

zinc diacetate
557-34-6

zinc diacetate

Zn(C12H13O3)2

Zn(C12H13O3)2

Conditions
ConditionsYield
In dimethyl sulfoxide stirring; filtn., washing (DMSO, hot H2O, acetone), drying (60°C, 24 h); elem. anal.;100%

557-34-6Relevant articles and documents

Zinc-containing block copolymer as a precursor for the in situ formation of nano ZnO and PMMA/ZnO nanocomposites

Kos, Tomaz,Anzlovar, Alojz,Pahovnik, David,Zagar, Ema,Orel, Zorica Crnjak,Zigon, Majda

, p. 6942 - 6948 (2013)

We report on the synthesis of highly transparent and UV-absorbing PMMA/ZnO nanocomposites prepared by hydrolysis of a ZnO precursor, the A-b-(AB) diblock copolymer, poly(methyl methacrylate)-block-poly(methyl methacrylate-co-(zinc methacrylate acetate)), PMMA-b-P(MMA-co-ZnMAAc), synthesized by RAFT polymerization. The zinc content of the block copolymers was in the range from 3 to 13 wt %. The PMMA block provides inherent compatibility with the PMMA matrix, whereas the second block, P(MMA-co-ZnMAAc) with zinc ions, acts as a polymeric precursor for the formation of ZnO nanoparticles. The amphiphilic block copolymer self-organizes in THF and THF/H2O in ordered nanostructures, thereby influencing the nanoparticle formation during the hydrolysis of the precursor block copolymer with KOH in a solvent mixture THF/H2O. The ZnO nanoparticles were rod-shaped with lengths up to 80 nm and a diameter of 14 nm and were redispersible in THF. Dispersions in THF and thin films of PMMA/ZnO nanocomposite exhibit excellent transparency in the visible range and good absorption in the UV range below 400 nm. The block copolymer was characterized by SEC, NMR, DLS, and TGA, while PMMA/ZnO nanocomposites were characterized by IR, XRD, UV-vis, and STEM.

Kinetics and mechanism of the isothermal dehydration of zinc acetate dihydrate

Koga, Nobuyoshi,Tanaka, Haruhiko

, p. 69 - 76 (1997)

The overall kinetics of the thermal dehydration of zinc acetate dihydrate was investigated by means of isothermal mass-change measurements, complemented by microscopic observations of the reaction geometry and morphological change during the reaction. Under isothermal conditions, the compound loses its water of crystallization in a well-defined single step; Zn(CH3COO)2 · 2H2O → Zn(CH3COO)2 + 2H2O. The microscopic observations for the single crystals confirm that the reaction initiates at the edge surfaces of the hexagonal thin plate by nucleation and growth processes, consequently forming the reaction interface which advances inward, toward the center of the hexagon. The kinetic results obtained from the thermoanalytical measurements indicated agreement to the first-order law, in spite of the two-dimensional shrinkage of the reaction interface. This discrepancy is discussed in connection with the interactions of the elementary nucleation and growth processes at the reaction interfaces with the self-generated water vapor. The overall kinetic behavior of the crushed crystals of different particle-size fractions, under various atmospheric conditions, was investigated. The apparent kinetic results varied systematically with the sample and atmospheric conditions, accompanied by changes of the roles of surface reaction, diffusion of evolved water vapor from the reaction interface and gross diffusion of water vapor through the assemblage of sample particles.

Thermal stability of new zinc acetate-based complex compounds

Gyoryova,Balek

, p. 519 - 532 (1993)

The compounds were characterized by IR spectroscopy, chemical analysis and thermal analysis. Thermal analysis showed that no changes in crystallographic modifications of the compounds take place during (heating in nitrogen before) the thermal decompositio

Zn(II) carboxylates containing heterocyclic secondary ligands: synthesis and structure manifestation through DFT studies

Zahoor, Ayesha,Imtiaz-Ud-Din,Andleeb, Sohaila,Raheel, Ahmad,Ayub, Rabia,Abbas, Sumaira,Tahir, Muhammad Nawaz

, p. 1978 - 1991 (2021)

New Zn(II) complexes (1–8) of general formula [Zn(R)2(L')2], where R = cinnamic acid (1–7), L' = 3-pyridine carboxamide (1), 2,2'-bipyridine (2), 3-pyridinecarbonitrile (3), 2-amino-5-(4-pyridinyl)-1,3,4-thiadiazole (4), 2-methylimidazole (5), 2-phenylimidazole (6), 2-imidazolidinethione (7) and for (8), R = acetic acid; L' = 2-amino-5-(4-pyridinyl)-1,3,4-thiadiazole)2, have been synthesized by a stoichiometric reaction between Zn(II) carboxylate(s) and the respective nitrogen-based ligands. The prepared compounds are analyzed by FTIR, NMR spectroscopy and single crystal X-ray diffraction techniques for their structural manifestations along with elemental analyses. The crystallographic data for 6 and 8 exhibit four-coordinated zinc having distorted tetrahedral molecular geometry. The thermogravimetric data demonstrate high stability of the compounds with gradual loss of acetate and thiadiazol fragments that ultimately lead to zinc oxide as the residual mass of 8. Quantum chemical calculations indicate that 7 is the softest in reactivity having the lowest band gap as determined from the energies of frontier molecular orbitals whereas 8 is highly polar with the highest dipole moment value of 12.61 D. The computational data are a complement to the success of the research.

A phosgene-free process for the synthesis of methyl N-phenyl carbamate by the reaction of aniline with methyl carbamate

Li, Qi-Feng,Wang, Jun-Wei,Dong, Wen-Sheng,Kang, Mao-Qing,Wang, Xin-Kui,Peng, Shao-Yi

, p. 99 - 105 (2004)

A phosgene-free route for the synthesis of methyl N-phenyl carbamate (MPC) by the reaction of aniline with methyl carbamate in the presence of methanol was studied. Effects of catalysts, reaction temperature, reaction time, and catalyst content, the molar ratio of reactants and the content of water on the reaction were investigated. The results demonstrated that an aniline conversion of 90.1% and MPC selectivity of 99.7% were achieved when the reaction was carried out at 433 K for 4 h using ZnCl2 as a catalyst. A possible reaction mechanism was proposed based on the product distribution.

Controllable fabrication of various ZnO micro/nanostructures from a wire-like Zn-EG-AC precursor via a facile solution-based route

Tian, Chungui,Li, Wei,Zhang, Qi,Pan, Kai,Fu, Honggang

, p. 1283 - 1289 (2011)

In this paper, ZnO particles with various morphologies were prepared though a facile solution-based route. The complexes Zn-EG-AC (EG: ethylene glycol; AC: CH3COO- groups) obtained by reaction of anhydrous zinc acetate and EG were used as precursors. It is found that the precursor could transform into ZnO in water with no need of assistant of additional alkali as it is sensitive to water. At the same time, it is well dispersed in reaction medium (water and ethanol). Experimental results showed that ZnO particles with various morphologies, such as the hexagonal rings, the hexagonal plates, the tubes, the prisms, and some interesting hierarchical structures, could be obtained by controlling hydrolysis of precursor in water and water/ethanol medium through finely tuning the experimental parameters. The success of shape-controllable fabrication was related intimately with the Zn-EG-AC precursor used in our synthesis.

Zinc-67 NMR study of tetrahedral and octahedral zinc sites with symmetrical oxygen, nitrogen, and sulfur ligands

Sham, Simon,Wu, Gang

, p. 1782 - 1787 (1999)

We report a 67Zn nuclear magnetic resonance (NMR) study of compounds containing zinc ions coordinated by oxygen, nitrogen, and sulfur ligands. New information concerning 67Zn nuclear quadrupole coupling constants (NQCC) and chemical shift was obtained from magic-angle spinning (MAS) spectra of solid compounds containing both natural abundance and enriched 67Zn isotopes. Rapid ligand exchange processes of [Zn(thiourea)4]2+ in aqueous solutions were also observed.

Davidson, A. W.,McAllister, W. H.

, p. 519 - 527 (1930)

COMPACT AND HOMOGENEOUS QUANTUM DOTS AND METHODS OF MAKING THE SAME

-

, (2020/02/10)

The present disclosure provides quantum dots and methods of making the quantum dots comprising a substantially homogeneous population of monomeric nanocrystals, of a very small size, about 7 nm to about 12 nm in diameter. The method comprises mixing a nanocrystal coated with weakly binding ligands or ions with a polymer in a solution and incubating at a temperature greater than about 100° C., thereby forming a quantum dot having a substantially homogenous population of monomeric nanocrystals. The quantum dots can be further conjugated to bioaffinity molecules, enabling broad utilization of compact, biofunctional quantum dots for studying crowded macromolecular environments.

Oral Care Compositions and Methods of Use

-

Paragraph 0104-0105, (2019/02/05)

Disclosed herein are oral care compositions including Zn:usnate complexes having a 1:2 zinc to usnate molar ratio. Methods of making and using the compositions are also provided.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 557-34-6